Nervous system complications of COVID-19 with a focus on stroke.
Angiotensin-Converting Enzyme 2
/ metabolism
Anosmia
/ physiopathology
Anticoagulants
/ therapeutic use
Blood Coagulation Disorders
/ complications
COVID-19
/ complications
Consciousness Disorders
/ physiopathology
Cytokines
/ immunology
Endothelium, Vascular
/ metabolism
Headache
/ physiopathology
Humans
Receptors, Coronavirus
/ metabolism
Renin-Angiotensin System
SARS-CoV-2
Stockings, Compression
Stroke
/ etiology
Taste Disorders
/ physiopathology
Thrombolytic Therapy
Journal
European review for medical and pharmacological sciences
ISSN: 2284-0729
Titre abrégé: Eur Rev Med Pharmacol Sci
Pays: Italy
ID NLM: 9717360
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
entrez:
30
12
2020
pubmed:
31
12
2020
medline:
9
1
2021
Statut:
ppublish
Résumé
As a severe and highly contagious infection, coronavirus disease (COVID-19) affects all aspects of society and has become a global public health problem. Because of the complexity of the pathology of COVID-19, it is difficult to treat. An increasing number of reports have indicated that COVID-19 may have neurological complications, including stroke. The nervous system complications of COVID-19 have gradually attracted research attention. In this review, we summarize the latest findings related to COVID 19, elaborate on the possible mechanism of COVID 19 related onset of stroke, and summarize current treatment options because an improved understanding and appropriate treatments may improve the prognosis of patients with COVID-19-related stroke.
Identifiants
pubmed: 33378056
doi: 10.26355/eurrev_202012_24210
pii:
doi:
Substances chimiques
Anticoagulants
0
Cytokines
0
Receptors, Coronavirus
0
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM